Search

Zai Lab Ltd ADR

Geschlossen

BrancheGesundheitswesen

24.11 -6.11

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

25.35

Max

26.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

191K

-51M

Verkäufe

6.7M

106M

EPS

-0.46

Gewinnspanne

-47.808

Angestellte

1,784

EBITDA

-2.1M

-46M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+49.33% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

831M

2.9B

Vorheriger Eröffnungskurs

30.22

Vorheriger Schlusskurs

24.11

Nachrichtenstimmung

By Acuity

50%

50%

107 / 339 Ranking in Healthcare

Zai Lab Ltd ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

30. Sept. 2026, 23:42 UTC

News
Correlated Moves

Albertsons Companies Inc appointed Cody Perdue as Interim CFO and announced new board members, with shares trading higher in after-market hours.

30. Sept. 2026, 23:41 UTC

News

Norwegian Cruise Line Holdings Ltd. has priced $950 million in senior notes due 2031, with shares modestly higher in after-market trading.

30. Sept. 2026, 23:40 UTC

News

Apple Inc. is implementing organizational changes under CEO John Ternus, resulting in modestly higher shares during after-market hours.

30. Sept. 2026, 23:40 UTC

News

MGIC Investment Corp's shares rose in after-market trading, recovering from recent declines amid ongoing sector pressures from rising mortgage rates and reduced housing demand.

30. Sept. 2026, 23:35 UTC

News

Mattel's CEO, Ynon Kreiz, appointed co-CEO of the merged Paramount and Warner Bros. Discovery, as shares rise modestly in after-market trading.

30. Sept. 2026, 23:35 UTC

News

Photronics Inc's shares traded roughly flat in after-market hours following its announcement to participate in the 18th Annual CEO Investor Summit on October 13th.

30. Sept. 2026, 23:30 UTC

News
Event

Sarepta Therapeutics shares are trading higher in after-market hours following new data on ELEVIDYS presented at the World Muscle Society Congress.

30. Sept. 2026, 23:26 UTC

News
Event
Social Media

Micron Technology Inc's stock fell in after-hours trading following its Q4 earnings report, despite exceeding revenue and EPS estimates, amid concerns over future guidance.

30. Sept. 2026, 23:21 UTC

News

Standard BioTools Inc. agrees to sell its Mass Cytometry business to Element Biosystems, LLC for $5.5 million, boosting net cash by $15 million, shares rise in after-market trading.

30. Sept. 2026, 23:15 UTC

News

Guidewire Software Inc has signed a multi-year agreement with a top 10 U.S. insurance carrier, leading to a modest increase in after-market trading.

30. Sept. 2026, 23:15 UTC

News

Star Bulk Carriers Corp. is rising in after-market trading, supported by a significant increase in the Baltic Exchange’s dry bulk freight index.

30. Sept. 2026, 23:11 UTC

Social Media
News

Rocket Lab Corporation secured a multi-year agreement for 20 Electron launches with Synspective, boosting its backlog to over 100 missions, driving higher after-market trading.

30. Sept. 2026, 23:06 UTC

News

Visa Inc. is trading slightly higher in after-market hours, maintaining a position roughly flat since Wednesday's close amid limited movement and recent declines.

30. Sept. 2026, 23:06 UTC

Event
Social Media
News

Eli Lilly's shares rose in after-market hours following positive Phase 3 ACHIEVE-4 trial results for Foundayo, showing lower cardiovascular risks compared to insulin glargine.

30. Sept. 2026, 23:06 UTC

News

Lululemon Athletica Inc announced an extension with Chip Wilson to finalize a new director appointment, with shares slightly higher in after-market trading.

30. Sept. 2026, 23:06 UTC

News
Social Media

Kodiak Sciences is higher in after-market trading following Baker Bros Advisors' acquisition of 715k shares for $63.4 million, raising their stake to 35%.

30. Sept. 2026, 23:06 UTC

News
Correlated Moves

Delta Air Lines Inc. is trading modestly higher in after-market hours, supported by a quarterly dividend of $0.2150 per share and gains in major holdings.

30. Sept. 2026, 23:05 UTC

News

Conagra Brands Inc declined in after-market trading, following its Q1 fiscal year 2027 earnings call that noted strong results but no immediate developments.

30. Sept. 2026, 23:05 UTC

News

Verizon Communications Inc. is trading slightly higher in after-market hours, following CEO Dan Schulman's comments on advancements in artificial intelligence and an "AI-native" model.

30. Sept. 2026, 23:05 UTC

Social Media
News

Boeing Co has secured an order from Ethiopian Airlines for ten 777 Freighters and received U.S. defense contracts totaling over $207 million, trading higher in after-market hours.

30. Sept. 2026, 23:01 UTC

Social Media
News
Event

Vicor Corporation raised its Q3 2026 revenue growth guidance to over 30%, driven by increased royalties from its VPD technology, boosting shares in after-hours trading.

30. Sept. 2026, 23:01 UTC

News
Event
Social Media

Progress Software shares fell in after-market trading after Q3 results showed revenue of $246 million missed estimates, despite adjusted EPS of $1.69 exceeding expectations.

30. Sept. 2026, 23:01 UTC

News
Social Media

Liquidia Corp is appealing a court ruling on YUTREPIA patents, with shares modestly higher in after-market hours amid ongoing litigation challenges.

30. Sept. 2026, 23:01 UTC

News
Social Media

United Therapeutics shares rose in after-market trading following a court ruling that Liquidia infringed on its patent claims for inhaled treprostinil treatments.

30. Sept. 2026, 23:01 UTC

News

DoorDash Inc. has launched its delivery drone, DoorDash Air, set for pilot flights in Northern California, contributing to higher after-market trading shares.

30. Sept. 2026, 23:01 UTC

Social Media
News

Constellation Energy Corp's after-hours stock rises following a 20-year power purchase agreement with Amazon, adding 190 megawatts of nuclear capacity and $3 billion in investments.

30. Sept. 2026, 23:01 UTC

News
Event
Social Media

Synopsys projects fiscal year 2027 revenue of $11.15 billion and adjusted EPS of $19.04 to $19.12, trading higher in after-market hours.

30. Sept. 2026, 23:01 UTC

Social Media
News

Nu Holdings Ltd. clarified it is not pursuing a $10.6B to $13.3B acquisition of Monzo, leading to a significant stock price increase in after-market hours.

30. Sept. 2026, 23:01 UTC

Social Media
News

Madison Square Garden Sports Corp. announced a spin-off of its New York Rangers business, leading to a higher stock price in after-hours trading.

30. Sept. 2026, 23:01 UTC

Social Media
News

NextEra Energy, in partnership with Related Companies and Lewis Energy, announced Project Star, a $22.3 billion energy campus in Texas, boosting shares higher in after-market hours.

Peer-Vergleich

Kursveränderung

Zai Lab Ltd ADR Prognose

Kursziel

By TipRanks

49.33% Vorteil

12-Monats-Prognose

Durchschnitt 39.333 USD  49.33%

Hoch 45 USD

Tief 36 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Zai Lab Ltd ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Stimmung

By Acuity

107 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.